Agency Forms Undergoing Paperwork Reduction Act Review, 68887-68888 [2014-27350]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 223 / Wednesday, November 19, 2014 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–27352 Filed 11–18–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-15–14APM]
mstockstill on DSK4VPTVN1PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
VerDate Sep<11>2014
16:16 Nov 18, 2014
Jkt 235001
comments should be received within 30
days of this notice.
Proposed Project
Surveillance of Health-Related
Workplace Absenteeism—[New]—
National Institute for Occupational
Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
There is currently a high global
human health risk from emerging novel
influenza, coronavirus and similar
evolving pathogens, which is prompting
the Centers for Disease Control and
Prevention (CDC) to enhance situational
awareness capacity for emergency
preparedness and response.
During the 2009 influenza A (H1N1)
virus pandemic, NIOSH/CDC did a pilot
study to test the feasibility of using
national surveillance of workplace
absenteeism to assess the pandemic’s
impact on the workplace to plan for
preparedness and continuity of
operations and to contribute to health
awareness during the emergency
response. As part of this emergency
effort, CDC contracted with the
American College of Occupational and
Environmental Medicine (ACOEM),
which has access to a large network of
affiliated medical directors and
corporate health units that routinely
compile absenteeism data, to conduct
enhanced passive surveillance of
absenteeism using weekly data from a
convenience sample of sentinel
worksites.
Due the emergency situation at that
time, OMB approval was erroneously
not requested for the data collection
activities associated with the pilot
study. The current request seeks to
build off of the data collected from the
pilot and accounts for the burden
involving all of the participants.
From September 28, 2009, through
March 31, 2010, 79 sentinel worksites
representing 16 different employers
participated in the pilot study. Each
week, ACOEM collected reports of
aggregated absenteeism data from the
medical directors of the participating
companies using an emailed,
standardized form. ACOEM replaced
company names with coded unique
identifiers, and sent the aggregated data
to CDC/NIOSH for analysis.
The major strengths of the sentinel
worksite approach to absenteeism
surveillance were the use of existing,
routinely collected data and timeliness.
The use of existing, routinely collected
data made the burden on participating
companies negligible. Data were
routinely compiled and thus could be
collected and analyzed in near real time,
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
68887
making this approach useful, in
principle, for providing current
situational awareness and actionable
intelligence that could be used to
inform, prioritize, and evaluate
intervention efforts during the
pandemic. On the other hand, there
were several limitations to the sentinel
worksite surveillance done in 2009–
2010, and the activity was not
maintained after the H1N1 pandemic
ended.
At present, two new emerging
infectious diseases, novel H7N9
influenza virus and a coronavirus
circulating in the Middle East, have
demonstrated the need to build
additional capacity for national
surveillance for health-related
workplace absenteeism so that it can be
used to monitor the impact of these or
any other disease that might reach
pandemic potential and spread to the
U.S.
NIOSH/CDC requests permission to
collect company absenteeism data, to be
able to assess the impact of disease on
a company and to identify trends in the
spread of influenza or other novel
disease states. This will provide an
additional monitoring system to CDC.
The proposed project builds on the
2009/10 initiative and modifies the
reporting format to collect information
on a daily versus weekly basis. The
companies in the program will be those
that routinely collect absenteeism data
thus the burden will be minimal. We
will be asking companies to record their
daily absenteeism numbers into an excel
file which can be emailed to ACOEM on
a weekly or monthly basis. The excel
file will be pre-populated with company
name, site and dates to ease the
reporting burden on companies.
ACOEM will transmit de-identified
information on a weekly or monthly
basis to NIOSH/CDC who will in turn
conduct analysis on an aggregate basis.
Data will be compiled by state and HHS
region, as well as nationally to allow for
trend analysis.
The initial 16 respondents in the
2009/10 study will be asked to
participate and an additional 12
companies have indicated an interest in
participating in the data collection
activity. The employee population
among these 28 companies is
approximately 293,000.
The annualized estimated burden of
time is 607 hours for the 28 respondents
in the study. Respondents will complete
the form daily; no more than 5 minutes
per day/per respondent which translates
to 25 minutes per week/per respondent
or 700 minutes per week for all
respondents. This results in an
E:\FR\FM\19NON1.SGM
19NON1
68888
Federal Register / Vol. 79, No. 223 / Wednesday, November 19, 2014 / Notices
annualized burden of 607 hours per
year.
There are no costs to participants
other than the time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Private companies ..........................................
EXCEL data template ....................................
28
260
5/60
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–27350 Filed 11–18–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA Numbers: 93.592]
Announcing the Award of a SingleSource Program Expansion
Supplement Grant to the National
Resource Center on Domestic Violence
(NRCDV) in Harrisburg, PA
Family and Youth Services
Bureau, ACYF, ACF, HHS.
ACTION: Notice of the award of a singlesource program expansion supplement
grant under the Family Violence
Prevention and Services Act (FVPSA)
Technical Assistance (TA) Project to the
National Resource Center on Domestic
Violence to support training and
technical assistance activities.
AGENCY:
The Administration for
Children and Families (ACF),
Administration on Children, Youth and
Families (ACYF), Family and Youth
Services Bureau (FYSB), Division of
Family Violence and Prevention
Services (DFVPS) announces the award
of $236,000 as a single-source program
expansion supplement to the National
Resource Center on Domestic Violence
in Harrisburg, PA. The grantee, funded
under the Family Violence Protection
and Services Act (FVPSA) program, is a
technical assistance (TA) provider that
assists FVPSA service providers to build
the capacity of domestic violence
programs.
DATES: The period of support for the
single-source program expansion
supplement is September 30, 2014
through September 29, 2015.
FOR FURTHER INFORMATION CONTACT:
Shawndell Dawson, Senior Program
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:16 Nov 18, 2014
Jkt 235001
Specialist, Family Violence Prevention
and Services Program, 1250 Maryland
Avenue SW., Suite 8219, Washington,
DC 20024. Telephone: 202–205–1476;
Email: Shawndell.Dawson@acf.hhs.gov.
SUPPLEMENTARY INFORMATION:
Supplemental award funds will support
the grantee in providing training and
technical assistance to domestic
violence service providers. A portion of
the supplemental award is contributed
by the Centers for Disease Control (CDC)
and Prevention’s National Center for
Injury Prevention and Control (NCIPC),
Division of Violence Prevention (DVP).
This award will expand the scope of
the NRCDV’s technical assistance
activities to include additional activities
concerning the prevention of intimate
partner violence (IPV) by: (1)
Coordinating engagement with nationallevel partners, including foundations,
for the purpose of enhancing
communication related to IPV
prevention; 2) engaging in planning to
facilitate dialogue that will include the
sharing of tools and lessons learned
among state domestic violence
coalitions engaged in IPV primary
prevention efforts; 3) continuing to
identify and disseminate information on
lessons learned and key findings from
state domestic violence coalitions that
have implemented IPV primary
prevention activities through
www.PreventIPVorg, and other means;
4) maintaining a virtual workspace to
assist in the sharing of resources among
state and territorial domestic violence
coalitions that are engaged in IPV
primary prevention activities; and 5)
facilitating regular, ongoing
communication between the IPV
Prevention Council, ACF/DFVPS, and
CDC/DVP.
In addition to the prevention
activities, the grantee will coordinate an
accessibility and sustainability peer-topeer technical assistance collaborative
with three to five state domestic
violence coalitions, which may involve
activities such as: (1) Identifying state
coalitions with experience in addressing
organizational accessibility challenges
(i.e. mental health, substance use, men,
and adolescent boys), or sustainability
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
challenges (i.e. fiscal management or
board management); (2) coordinating
support to domestic violence
organizations or coalitions experiencing
accessibility or sustainability
challenges; and (3) developing peerinformed accessibility and sustainability
tools and resources, and a discussion
forum, for use by all domestic violence
coalitions.
Statutory Authority: Section 310 of the
Family Violence Prevention and Services
Act, as amended by Section 201 of the
CAPTA Reauthorization Act of 2010, Pub. L.
111–320. The statutory authority for the
additional funds from the Centers for Disease
Control and Prevention is 42 U.S.C.
247b(k)(2) and 42 USC 280b–1 of the Public
Health Service Act.
Christopher Beach,
Senior Grants Policy Specialist, Division of
Grants Policy, Office of Administration.
[FR Doc. 2014–27390 Filed 11–18–14; 8:45 am]
BILLING CODE 4184–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1855]
Agency Information Collection
Activities; Proposed Collection;
Comment Request: Experimental
Studies on Consumer Perceptions of
Modified Risk Tobacco Products
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
Experimental Studies on Consumer
Perceptions of Modified Risk Tobacco
Products (MRTPs).
SUMMARY:
E:\FR\FM\19NON1.SGM
19NON1
]]>Agencies
[Federal Register Volume 79, Number 223 (Wednesday, November 19, 2014)]
[Notices]
[Pages 68887-68888]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27350]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-15-14APM]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Surveillance of Health-Related Workplace Absenteeism--[New]--
National Institute for Occupational Safety and Health (NIOSH), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
There is currently a high global human health risk from emerging
novel influenza, coronavirus and similar evolving pathogens, which is
prompting the Centers for Disease Control and Prevention (CDC) to
enhance situational awareness capacity for emergency preparedness and
response.
During the 2009 influenza A (H1N1) virus pandemic, NIOSH/CDC did a
pilot study to test the feasibility of using national surveillance of
workplace absenteeism to assess the pandemic's impact on the workplace
to plan for preparedness and continuity of operations and to contribute
to health awareness during the emergency response. As part of this
emergency effort, CDC contracted with the American College of
Occupational and Environmental Medicine (ACOEM), which has access to a
large network of affiliated medical directors and corporate health
units that routinely compile absenteeism data, to conduct enhanced
passive surveillance of absenteeism using weekly data from a
convenience sample of sentinel worksites.
Due the emergency situation at that time, OMB approval was
erroneously not requested for the data collection activities associated
with the pilot study. The current request seeks to build off of the
data collected from the pilot and accounts for the burden involving all
of the participants.
From September 28, 2009, through March 31, 2010, 79 sentinel
worksites representing 16 different employers participated in the pilot
study. Each week, ACOEM collected reports of aggregated absenteeism
data from the medical directors of the participating companies using an
emailed, standardized form. ACOEM replaced company names with coded
unique identifiers, and sent the aggregated data to CDC/NIOSH for
analysis.
The major strengths of the sentinel worksite approach to
absenteeism surveillance were the use of existing, routinely collected
data and timeliness. The use of existing, routinely collected data made
the burden on participating companies negligible. Data were routinely
compiled and thus could be collected and analyzed in near real time,
making this approach useful, in principle, for providing current
situational awareness and actionable intelligence that could be used to
inform, prioritize, and evaluate intervention efforts during the
pandemic. On the other hand, there were several limitations to the
sentinel worksite surveillance done in 2009-2010, and the activity was
not maintained after the H1N1 pandemic ended.
At present, two new emerging infectious diseases, novel H7N9
influenza virus and a coronavirus circulating in the Middle East, have
demonstrated the need to build additional capacity for national
surveillance for health-related workplace absenteeism so that it can be
used to monitor the impact of these or any other disease that might
reach pandemic potential and spread to the U.S.
NIOSH/CDC requests permission to collect company absenteeism data,
to be able to assess the impact of disease on a company and to identify
trends in the spread of influenza or other novel disease states. This
will provide an additional monitoring system to CDC. The proposed
project builds on the 2009/10 initiative and modifies the reporting
format to collect information on a daily versus weekly basis. The
companies in the program will be those that routinely collect
absenteeism data thus the burden will be minimal. We will be asking
companies to record their daily absenteeism numbers into an excel file
which can be emailed to ACOEM on a weekly or monthly basis. The excel
file will be pre-populated with company name, site and dates to ease
the reporting burden on companies.
ACOEM will transmit de-identified information on a weekly or
monthly basis to NIOSH/CDC who will in turn conduct analysis on an
aggregate basis. Data will be compiled by state and HHS region, as well
as nationally to allow for trend analysis.
The initial 16 respondents in the 2009/10 study will be asked to
participate and an additional 12 companies have indicated an interest
in participating in the data collection activity. The employee
population among these 28 companies is approximately 293,000.
The annualized estimated burden of time is 607 hours for the 28
respondents in the study. Respondents will complete the form daily; no
more than 5 minutes per day/per respondent which translates to 25
minutes per week/per respondent or 700 minutes per week for all
respondents. This results in an
[[Page 68888]]
annualized burden of 607 hours per year.
There are no costs to participants other than the time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Private companies................... EXCEL data template.... 28 260 5/60
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-27350 Filed 11-18-14; 8:45 am]
BILLING CODE 4163-18-P
